Francisco Partners to Sell Medication Management Company Aesynt to Omnicell

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Francisco Partners to Sell Medication Management Company Aesynt to Omnicell

Lower Revenues and Guidance on Omnicell (OMCL) Raises Concerns; Cowen Cuts Price Target to $29

October 30, 2015 8:24 AM EDT

Cowen maintained a Market Perform rating on Omnicell (NASDAQ: OMCL), and cut the price target to $29.00 (from $37.00), following the company's 3Q earnings results. OMCL reported 3Q adjusted EPS of $0.36, in-line with consensus expectations. Revenues slightly missed this quarter coming in at $125.2M, up 11.3%... More